Filter
684
Featured
85
211
Language
Document type
407
131
82
31
11
8
8
2
2
1
1
Countries
51
27
18
15
15
15
13
11
10
10
9
9
8
8
8
7
7
7
7
7
7
7
6
6
6
4
4
4
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
252
130
35
33
15
15
10
Toolboxes
100
89
63
40
32
16
16
15
10
8
8
5
5
4
4
3
2
2
2
2
1
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Evaluation report
January 2014
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
Accessed: 07.11.2019
Accessed: 26.11.2019
HIV i-Base
July 2018
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
www.i-Base.info
Accessed: 28.11.2019
After completing this activity, pharmacists should be able to:
1. List populations for which the compounding of an oral liquid may be necessary
2. Outline necessary considerations that should be made by the pharmacist to ensure product stability
3. Describe methods used in the compounding of liqu
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Towards ending tuberculosis and multidrug-resistant tuberculosis.
A Guide For Multicentre Trials in High-Burden Countries
